<DOC>
	<DOCNO>NCT02659722</DOCNO>
	<brief_summary>The primary objective prospective , post-market study collect data assess long term outcome broad contact modular interbody device form InterFuse S™ InterFuse T™ device patient undergo long construct fusion degenerative disc disease and/or scoliosis . Comparisons make publish historical data..</brief_summary>
	<brief_title>InterFuse® S T Treatment Scoliosis , Spondylolisthesis Degenerative Disc Disease ( DDD )</brief_title>
	<detailed_description>The primary objective prospective , post-market study collect data assess long term outcome broad contact modular interbody device form InterFuse S™ InterFuse T™ device patient undergo long construct fusion degenerative disc disease and/or scoliosis . While concurrent control population , ample historical control data use comparison . The study include two hundred ( 200 ) patient , 10 center , provide prospective evaluation InterFuse `` T '' and/or InterFuse `` S '' Interbody Fusion System . Primary endpoint assess twelve month post-surgery . All patient enrol study follow least 24 month .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Scoliosis</mesh_term>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . The patient plan fusion construct least five level InterFuse ( S ) ( T ) plan L5S1 and/or L4L5 . 2 . The patient document conservative ( nonoperative ) treatment least 6 month . 3 . The patient VAS score ≥ 60 mm Back and/or Leg . 4 . The patient ODI ≥ 40 % . 5 . The general condition patient appropriate surgery , evaluate Investigator . 6 . The patient willing able comply study requirement . 7 . The patient agree participate study 1 . The patient undergone prior spinal fusion surgery propose treatment level ( ) . Previous nonfusion surgery propose treatment level ( ) acceptable . 2 . The patient osteoporosis severe osteopenia determine Investigator . A clinical SCORE calculator may utilize female 40 year age . 3 . The patient grade 2 high spondylolisthesis retrolisthesis affect level ( ) . 4 . The patient know neoplastic disease skin cancer . 5 . The patient Body Mass Index ( BMI ) great 40 ; BMI = wt ( kg ) /ht2 ( m2 ) . 6 . The patient active infection . 7 . The patient pregnant plan become pregnant next two year . 8 . The patient mentally ill history drug abuse severe depression/ psychosocial issue . 9 . The patient know allergy polyether ether ketone ( PEEK ) , stainless steel tantalum . 10 . The patient currently enrol investigational spine study . 11 . The patient rheumatoid arthritis , ankylose spondylitis autoimmune disease . 12 . The patient symptomatic fibrous arachroiditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>INTERVERTEBRAL DISC DEGENERATION</keyword>
	<keyword>Bone Disease</keyword>
	<keyword>Musculoskeletal disease</keyword>
	<keyword>Spinal disease</keyword>
</DOC>